Post-operative cardiac surveillance
Continuous monitoring after PCI or CABG through the early recovery period, supporting surveillance for changes that may need clinical review.
LifePath-C · International
Advanced ambulatory cardiac monitoring, with no capital cost to adopt.
LifePath-C International combines wearable 6/12-lead ECG monitoring, expanded cardiac analysis, and multi-parameter physiological monitoring in one connected platform for selected international markets.
Designed for clinical programs including post-operative cardiac surveillance, arrhythmia workup, and preventive cardiac screening.
Hardware is never sold; it is a recurring-service model, so there is no capital outlay for the hospital.
- Status
- Available in licensed international markets
Where it’s used
Built for cardiac surveillance and workup.
Arrhythmia workup
Extended ambulatory monitoring can capture intermittent cardiac events that a brief in-clinic ECG or single-day recording may miss.
Preventive screening
Spot checks and continuous cardiac monitoring for at-risk patients, run as part of a structured preventive screening program.
Cardiac analysis
One device, a broader workup.
Atrial fibrillation / flutter
Supraventricular arrhythmias
Ventricular arrhythmias
Bradyarrhythmias
Conduction abnormalities (AV block, pause)
ST-segment pattern analysis
QT/QTc monitoring
Rhythm and morphology assessment
Multi-parameter monitoring
Broader physiological context.
LifePath-C International combines cardiac monitoring with additional physiological parameters to provide broader context around the patient’s condition.
Heart rate variability
Respiration
Skin temperature
Posture
Activity
Available in select international markets
Optional Elastic Care-managed clinical response.
Intelligent analysis
Combines signal processing, rule-based analysis, and machine-learning-assisted classification, with clinical oversight built into the workflow. The platform supports identification and classification; clinical judgment stays with the care team.
Technician over-read
For international deployments, an optional Elastic Care-managed clinical response service can provide technician over-read.
Bring advanced cardiac monitoring to your patients.
Request a pilotLifePath RPM is cleared by the FDA under 510(k). LifePath-C is currently under FDA 510(k) review and is not available for sale or clinical use in the United States. Elastic Care-managed monitoring services are currently available only in select international markets and may not be available in all jurisdictions. Product availability, indications for use, and detection capabilities vary by jurisdiction and are subject to local clearance or licensing. Information on this site is for general informational purposes and is not medical advice.